Academic article

• Lura, Njål; Wagner-Larsen, Kari Strøno; Ryste, Stian Torkildson et al. (2025). Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer. (external link)
• Wagner-Larsen, Kari Strøno; Lura, Njål; Gulati, Ankush et al. (2025). MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer. (external link)
• Hjelmeland, Marta Espevold; Lien, Hilde Eide; Berg, Hege Fredriksen et al. (2024). Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer. (external link)
• Luijten, Maartje M. W.; van Weelden, Willem Jan; Lalisang, Roy I. et al. (2024). Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma. (external link)
• Krakstad, Camilla; Berg, Hege Fredriksen; Lindemann, Kristina Yvonne Kathe et al. (2024). Frequency of ERBB2-Low Expression in Endometrial Cancer. (external link)
• Hodneland, Erlend; Andersen, Erling; Wagner-Larsen, Kari Strøno et al. (2024). Impact of MRI radiomic feature normalization for prognostic modelling in uterine endometrial and cervical cancers. (external link)
• Berg, Madeleine Bjørckenfeldt; Berg, Hege Fredriksen; Stokowy, Tomasz et al. (2024). Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. (external link)
• Espedal, Heidi; Fasmer, Kristine Eldevik; Berg, Hege Fredriksen et al. (2024). MRI radiomics captures early treatment response in patient-derived organoid endometrial cancer mouse models. (external link)
• Halle, Mari Kyllesø; Hodneland, Erlend; Wagner-Larsen, Kari Strøno et al. (2024). Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer. (external link)
• Halle, Mari Kyllesø; Bozickovic, Olivera; Forsse, David Erik et al. (2024). Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer. (external link)
• Bellone, Stefania; Jeong, Kyungjo; Halle, Mari Kyllesø et al. (2024). Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix. (external link)
• Wagner-Larsen, Kari Strøno; Hodneland, Erlend; Fasmer, Kristine Eldevik et al. (2023). MRI-based radiomic signatures for pretreatment prognostication in cervical cancer. (external link)
• Lombaers, Marike S.; Cornel, Karlijn M. C.; Visser, Nicole C. M. et al. (2023). Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer. (external link)
• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. (external link)
• Torkildsen, Cecilie Fredvik; Thomsen, Liv Cecilie Vestrheim; Sande, Ragnar et al. (2023). Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. (external link)
• Bredin, Hanna Kosberg; Krakstad, Camilla; Høivik, Erling André (2023). PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis. (external link)
• Eide, Agnes Jørgensen; Halle, Mari Kyllesø; Lura, Njål et al. (2023). Visceral fat percentage for prediction of outcome in uterine cervical cancer. (external link)
• Hodneland, Erlend; Kaliyugarasan, Sathiesh Kumar; Wagner-Larsen, Kari Strøno et al. (2022). Fully Automatic Whole-Volume Tumor Segmentation in Cervical Cancer. (external link)
• Fasmer, Kristine Eldevik; Gulati, Ankush; Dybvik, Julie Andrea et al. (2022). Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?. (external link)
• Dybvik, Julie Andrea; Fasmer, Kristine Eldevik; Ytre-Hauge, Sigmund et al. (2022). MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. (external link)
• Wagner-Larsen, Kari Strøno; Lura, Njål Gjærde; Salvesen, Øyvind et al. (2022). Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer. (external link)
• Sofiyeva, Nigar; Krakstad, Camilla; Halle, Mari Kyllesø et al. (2022). APOBEC3A/B deletion polymorphism and endometrial cancer risk. (external link)
• Lura, Njål Gjærde; Wagner-Larsen, Kari Strøno; Forsse, David Erik et al. (2022). What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?. (external link)
• Chakravarthy, Ankur; Reddin, Ian; Henderson, Stephen et al. (2022). Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance. (external link)
• Berg, Hege Fredriksen; Engerud, Hilde Renate; Myrvold, Madeleine et al. (2022). Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value. (external link)
• Hodneland, Erlend; Dybvik, Julie Andrea; Wagner-Larsen, Kari Strøno et al. (2021). Automated segmentation of endometrial cancer on MR images using deep learning. (external link)
• Fonnes, Tina; Telle, Ingrid Ovidia Moe; Forsse, David Erik et al. (2021). Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers. (external link)
• Halle, Mari Kyllesø; Sødal, Marte; Forsse, David Erik et al. (2021). A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. (external link)
• Espedal, Heidi; Berg, Hege Fredriksen; Fonnes, Tina et al. (2021). Feasibility and utility of MRI and dynamic 18F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer. (external link)
• Vrede, S.W.; van Weelden, Willem Jan; Visser, Nicole C.M. et al. (2021). Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. (external link)
• Halle, Mari Kyllesø; Munk, Ane Cecilie Dæhli; Engesæter, Birgit Øvstebø et al. (2021). A gene signature identifying CIN3 regression and cervical cancer survival. (external link)
• Øvestad, Irene Tveiterås; Engesæter, Birgit Øvstebø; Halle, Mari Kyllesø et al. (2021). High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling. (external link)
• van Weelden, Willem Jan; Reijnen, Casper; Küsters-Vandevelde, Heidi V.N. et al. (2021). The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study. (external link)
• Høivik, Erling Andre; Hodneland, Erlend; Dybvik, Julie Andrea et al. (2021). A radiogenomics application for prognostic profiling of endometrial cancer. (external link)
• Forsse, David Erik; Barbero, Mark Lewis B Barbero; Werner, Henrica Maria Johanna et al. (2021). Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study. (external link)
• Jacob, Havjin; Dybvik, Julie Andrea; Ytre-Hauge, Sigmund et al. (2021). An mri-based radiomic prognostic index predicts poor outcome and specific genetic alterations in endometrial cancer. (external link)
• Ruiz, Fiona J.; Sundaresan, Aishwarya; Zhang, Jin et al. (2021). Genomic characterization and therapeutic targeting of HPV undetected cervical carcinomas. (external link)
• Mazloumi Gavgani, Fatemeh; Karlsson, Thomas; Tangen, Ingvild Løberg et al. (2021). Nuclear upregulation of class I phosphoinositide 3-kinase p110β correlates with high 47S rRNA levels in cancer cells. (external link)
• Halle, Mari Kyllesø; Sundaresan, Aishwarya; Zhang, Jianqing et al. (2021). Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.. (external link)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (external link)
• Amant, Frederic; Mccluggage, W. Glenn; Werner, Henrica Maria Johanna et al. (2021). Incorporating molecular profiling into endometrial cancer management requires prospective studies. (external link)
• van Weelden, Willem Jan; Lalisang, Roy I; Bulten, Johan et al. (2021). Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer. (external link)
• Mörth, Eric; Wagner-Larsen, Kari Strøno; Hodneland, Erlend et al. (2020). RadEx: Integrated visual exploration of multiparametric studies for radiomic tumor profiling. (external link)
• Fasmer, Kristine Eldevik; Hodneland, Erlend; Dybvik, Julie Andrea et al. (2020). Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer. (external link)
• Reijnen, Casper; Gogou, Evangelia; Visser, Nicole C.M. et al. (2020). Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. (external link)
• Fonnes, Tina; Strand, Elin; Fasmer, Kristine Eldevik et al. (2020). Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. (external link)
• Ytre-Hauge, Sigmund; Salvesen, Øyvind; Krakstad, Camilla et al. (2020). Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer. (external link)
• Fasmer, Kristine Eldevik; Gulati, Ankush; Dybvik, Julie Andrea et al. (2020). Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. (external link)
• Engerud, Hilde Renate; Berg, Hege Fredriksen; Myrvold, Madeleine et al. (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. (external link)
• Berg, Hege Fredriksen; Ju, Zhenlin; Myrvold, Madeleine et al. (2020). Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma. (external link)
• Forsse, David Erik; Berg, Hege Fredriksen; Bozickovic, Olivera et al. (2020). Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. (external link)
• Engerud, Hilde Renate; Hope, Kirsten Øvergaard; Berg, Hege Fredriksen et al. (2019). Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. (external link)
• Holst, Frederik; Werner, Henrica Maria Johanna; Mjøs, Siv et al. (2019). PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. (external link)
• Reijnen, Casper; van Weelden, Willem Jan; Arts, Martijn S.J.P. et al. (2019). Poor outcome in hypoxic endometrial carcinoma is related to vascular density. (external link)
• Visser, Nicole C.M.; van der Putten, Louis J.M.; van Egerschot, Alex et al. (2019). Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study. (external link)
• Røsland, Gro Vatne; Dyrstad, Sissel Elisabeth; Tusubira, Deusdedit et al. (2019). Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC.. (external link)
• van Weelden, Willem Jan; Fasmer, Kristine Eldevik; Tangen, Ingvild Løberg et al. (2019). Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: A retrospective study. (external link)
• Forsse, David Erik; Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik et al. (2019). Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. (external link)
• Strand, Elin; Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik et al. (2019). Blood metabolites associate with prognosis in endometrial cancer. (external link)
• Konings, Gonda F.J.; Saarinen, Niina; Delvoux, Bert et al. (2018). Development of an image-guided orthotopic xenograft mouse model of endometrial cancer with controllable estrogen exposure. (external link)
• Fonnes, Tina; Trovik, Jone; Edqvist, Per-Henrik D. et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (external link)
• O'Mara, Tracy A.; Glubb, Dylan M.; Amant, Frédéric et al. (2018). Identification of nine new susceptibility loci for endometrial cancer. (external link)
• Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik; Konings, Gonda F et al. (2018). Blood steroids are associated with prognosis and fat distribution in endometrial cancer. (external link)
• Kelemen, Linda E.; Earp, Madalene; Fridley, Brooke L. et al. (2018). rs495139 in the TYMS-ENOSF1 region and risk of ovarian carcinoma of mucinous histology. (external link)
• Ytre-Hauge, Sigmund; Dybvik, Julie Andrea; Lundervold, Arvid et al. (2018). Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. (external link)
• Earp, Madalene; Tyrer, Jonathan P.; Winham, Stacey J. et al. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. (external link)
• Versluis, Mac; Plat, Annechien; de Bruyn, Marco et al. (2018). L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition. (external link)
• Fasmer, Kristine Eldevik; Bjørnerud, Atle; Ytre-Hauge, Sigmund et al. (2018). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. (external link)
• Kusonmano, Kanthida; Halle, Mari Kyllesø; Wik, Elisabeth et al. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. (external link)
• Painter, Jodie N.; O'Mara, Tracy A.; Morris, Andrew P. et al. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. (external link)
• Konings, Gonda F.J.; Cornel, Karlijn M.C.; Xanthoulea, Sofia et al. (2018). Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach. (external link)
• Bollineni, Vikram Rao; Ytre-Hauge, Sigmund; Gulati, Ankush et al. (2018). The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients. (external link)
• Halle, Mari Kyllesø; Ojesina, Akinyemi I; Engerud, Hilde Renate et al. (2017). Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. (external link)
• Fonnes, Tina; Berg, Hege Fredriksen; Onyango, Therese Bredholt et al. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. (external link)
• Tangen, Ingvild Løberg; Kopperud, Reidun Kristin; Visser, Nicole C.M. et al. (2017). Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients. (external link)
• Kopperud, Reidun Kristin; Rygh, Cecilie Brekke; Karlsen, Tine Veronica et al. (2017). Increased microvascular permeability in mice lacking Epac1 (Rapgef3). (external link)
• Mjøs, Siv; Werner, Henrica Maria Johanna; Birkeland, Even et al. (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. (external link)
• Karlsson, Thomas; Krakstad, Camilla; Tangen, Ingvild Løberg et al. (2017). Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation. (external link)
• Halle, Mari Kyllesø; Tangen, Ingvild Løberg; Berg, Hege Fredriksen et al. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. (external link)
• Mauland, Karen Klepsland; Ju, Zhenlin; Tangen, Ingvild Løberg et al. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. (external link)
• Eritja, Nuria; Jove, Mariona; Fasmer, Kristine Eldevik et al. (2017). Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. (external link)
• Mauland, Karen Klepsland; Eng, Øyvin Andre Solberg; Ytre-Hauge, Sigmund et al. (2017). High visceral fat percentage is associated with poor outcome in endometrial cancer. (external link)
• Tangen, Ingvild Løberg; Venereis, Jennifer Taylor; Halle, Mari Kyllesø et al. (2017). Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. (external link)
• Visser, Nicole C.M.; Werner, Henrica Maria Johanna; Krakstad, Camilla et al. (2017). Type of vascular invasion in association with progress of endometrial cancer. (external link)
• Berg, Anna; Gulati, Ankush; Ytre-Hauge, Sigmund et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (external link)
• Ytre-Hauge, Sigmund; Esmaeili, Morteza; Sjøbakk, Torill Eidhammer et al. (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. (external link)
• Tangen, Ingvild Løberg; Onyango, Therese Bredholt; Kopperud, Reidun Kristin et al. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. (external link)
• Gibson, William J.; Høivik, Erling Andre; Halle, Mari Kyllesø et al. (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. (external link)
• Cornel, KM; Krakstad, Camilla; Delvoux, B et al. (2016). High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer. (external link)
• Mauland, Karen Klepsland; Wik, Elisabeth; Høivik, Erling Andre et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (external link)
• Lee, Alice W; Templeman, Claire; Stram, Douglas A et al. (2016). Evidence of a genetic link between endometriosis and ovarian cancer. (external link)
• Hampras, Shalaka S.; Sucheston-Campbell, Lara E.; Cannioto, Rikki et al. (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. (external link)
• Berg, Anna; Fasmer, Kristine Eldevik; Mauland, Karen Klepsland et al. (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. (external link)
• Lawrenson, Kate; Iversen, Edwin S.; Tyrer, Jonathan et al. (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. (external link)
• Kelemen, Linda E.; Lawrenson, Kate; Tyrer, Jonathan et al. (2015). Genome-wide significant risk associations for mucinous ovarian carcinoma. (external link)
• Haldorsen, Ingfrid S.; Popa, Mihaela Lucia; Fonnes, Tina et al. (2015). Multimodal imaging of orthotopic mouse model of endometrial carcinoma. (external link)
• Westin, Shannon N.; Ju, Zhenlin; Broaddus, Russell R. et al. (2015). PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients. (external link)
• Lawrenson, Kate; Li, Qiyuan; Kar, Siddhartha et al. (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. (external link)
• Berg, Anna; Høivik, Erling Andre; Mjøs, Siv et al. (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. (external link)
• Alonso-Alconada, Lorena; Santacana, Maria; Garcia-Sanz, Pablo et al. (2015). Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. (external link)
• Kar, Siddhartha P.; Tyrer, Jonathan P.; Li, Qiyuan et al. (2015). Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. (external link)
• Krakstad, Camilla; Tangen, Ingvild Løberg; Høivik, Erling Andre et al. (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. (external link)
• Kuchenbäcker, Karoline B.; Ramus, Susan J.; Tyrer, Jonathan et al. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. (external link)
• Edqvist, Per-Henrik D.; Huvila, Jutta; Forsström, Björn et al. (2015). Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma. (external link)
• Amankwah, Ernest K.; Lin, Hui-Yi; Tyrer, Jonathan P. et al. (2015). Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. (external link)
• Chornokur, Ganna; Lin, Hui-Yi; Tyrer, Jonathan P. et al. (2015). Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk. (external link)
• Lee, Alice W.; Tyrer, Jonathan P; Doherty, Jennifer A et al. (2015). Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study. (external link)
• Ojesina, Akinyemi; Lichtenstein, Lee; Freeman, Samuel S. et al. (2014). Landscape of genomic alterations in cervical carcinomas. (external link)
• Herfindal, Lars; Krakstad, Camilla; Myhren, Lene Elisabeth et al. (2014). Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3. (external link)
• Wik, Elisabeth; Trovik, Jone; Kusonmano, Kanthida et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (external link)
• Werner, Henrica Maria Johanna; Trovik, Jone; Halle, Mari Kyllesø et al. (2014). Stathmin Protein Level, a Potential Peredictive Marker for Taxane Treatment Response in Endometrial Cancer. (external link)
• Charbonneau, Bridget; Block, MS; Bamlet, WR et al. (2014). Risk of ovarian cancer and the NF-kB pathway: Genetic association with IL1A and TNFSF10. (external link)
• Alonso-Alconada, Lorena; Muinelo-Romay, Laura; Madissoo, Kadri et al. (2014). Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. (external link)
• Tangen, Ingvild Løberg; Werner, Henrica Maria Johanna; Berg, Anna et al. (2014). Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions. (external link)
• Kelemen, Linda E.; Terry, Kathryn L.; Goodman, Marc T. et al. (2014). Consortium analysis of diet-gene interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.. (external link)
• Halle, Mari Kyllesø; Krakstad, Camilla; Engerud, Hilde Renate Haugen et al. (2014). Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix. (external link)
• Engerud, Hilde Renate Haugen; Tangen, Ingvild Løberg; Berg, Ansgar et al. (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. (external link)
• Tangen, Ingvild Løberg; Krakstad, Camilla; Halle, Mari Kyllesø et al. (2014). Switch in FOXA1 status associates with endometrial cancer progression. (external link)
• Høivik, Erling Andre; Kusonmano, Kanthida; Halle, Mari Kyllesø et al. (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. (external link)
• Ræder, Maria B; Birkeland, Even; Trovik, Jone et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (external link)
• Trovik, Jone; Wik, Elisabeth; Werner, Henrica Maria Johanna et al. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. (external link)
• Werner, Henrica Maria Johanna; Berg, Anna; Wik, Elisabeth et al. (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. (external link)
• Delahanty, Ryan J.; Xiang, Yong-Bing; Spurdle, Amanda et al. (2013). Polymorphisms in inflammation pathway genes and endometrial cancer risk. (external link)
• Herfindal, Lars; Nygaard, Gyrid; Kopperud, Reidun Kristin et al. (2013). Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets. (external link)
• Wik, Elisabeth; Ræder, Maria B; Krakstad, Camilla et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (external link)
• Bojesen, Stig E.; Pooley, Karen A; Johnatty, Sharon E et al. (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. (external link)
• Shen, Hui; Fridley, BL; Song, HL et al. (2013). Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. (external link)
• Pharoah, Paul D.P.; Halle, Mari Kyllesø; Krakstad, Camilla et al. (2013). GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. (external link)
• Permuth-Wey, Jennifer; Lawrenson, K; Shen, HC et al. (2013). Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. (external link)
• Wik, Elisabeth; Birkeland, Even; Trovik, Jone et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (external link)
• Long, Jirong; Zheng, Wei; Xiang, Yong-Bing et al. (2012). Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. (external link)
• Krakstad, Camilla; Trovik, Jone; Wik, Elisabeth et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (external link)
• Krakstad, Camilla; Birkeland, Even; Seidel, Danila et al. (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. (external link)
• Birkeland, Even; Wik, Elisabeth; Mjøs, Siv et al. (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. (external link)
• Herfindal, Lars; Myhren, Lene Elisabeth; Kleppe, Rune et al. (2011). Nostocyclopeptide-M1: A potent, nontoxic inhibitor of the hepatocyte drug transporters OATP1B3 and 1B1. (external link)
• Huseby, Sjur; Gausdal, Gro; Keen, Thomas Jeffrey et al. (2011). Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription. (external link)
• Birkeland, Even; Nygaard, G; Oveland, Eystein et al. (2009). Epac-induced Alterations in the Proteome of Human SH-SY5Y Neuroblastoma Cells. (external link)
• Chekenya, Martha; Krakstad, Camilla; Svendsen, Agnete et al. (2008). The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. (external link)
• Gausdal, Gro; Gjertsen, Bjørn Tore; McCormack, Emmet Martin et al. (2008). Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death. (external link)
• Krakstad, Camilla; Herfindal, Lars; Gjertsen, Bjørn Tore et al. (2006). CaM-kinasell-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. (external link)
• Krakstad, Camilla; Christensen, Anne Elisabeth; Døskeland, Stein Ove (2004). cAMP protects neutrophils against TNF?-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP (Epac). (external link)
• Kopperud, Reidun; Krakstad, Camilla; Selheim, Frode et al. (2003). cAMP effector mechanisms. Novel twists for an "old" signaling system. (external link)
• Tronstad, Karl Johan; Gjertsen, Bjørn Tore; Krakstad, Camilla et al. (2003). Mitochondrial-targeted fatty acid analog induces apoptosis with selective loss of mitochondrial glutathione in promyelocytic leukemia cells. (external link)
• Fladmark, Kari Espolin; Brustugun, Odd Terje; Mellgren, Gunnar et al. (2002). Ca2+/calmodulin dependent protein kinase II is required for microcystin-induced apoptosis. (external link)

Errata

• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595] (eBioMedicine (2023) 92, (S2352396423001603), (10.1016/j.ebiom.2023.104595)). (external link)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (external link)

Academic literature review

• Kasius, Jenneke C.; Pijnenborg, Johanna M. A.; Lindemann, Kristina et al. (2021). Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification. (external link)
• Obermair, Andreas; Baxter, Eva; Brennan, Donal J. et al. (2020). Fertility-sparing treatment in early endometrial cancer: Current state and future strategies. (external link)
• Baxter, Eva; Brennan, Donal J.; McAlpine, Jessica N. et al. (2020). Improving response to progestin treatment of low-grade endometrial cancer. (external link)
• Espedal, Heidi; Fonnes, Tina; Fasmer, Kristine Eldevik et al. (2019). Imaging of preclinical endometrial cancer models for monitoring tumor progression and response to targeted therapy. (external link)
• Mazloumi Gavgani, Fatemeh; Arnesen, Victoria Smith; Jacobsen, Rhian Gaenor et al. (2018). Class I Phosphoinositide 3-Kinase PIK3CA/p110α and PIK3CB/p110β Isoforms in Endometrial Cancer. (external link)
• Moiola, Cristian P.; Lopez-Gil, Carlos; Cabrera, Silvia et al. (2018). Patient-derived xenograft models for endometrial cancer research. (external link)
• Hollestelle, Antoinette; Van Der Baan, Frederieke H; Berchuck, Andrew et al. (2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (external link)
• Kleppe, Rune; Krakstad, Camilla; Selheim, Frode et al. (2011). The cAMP-dependent protein kinase pathway as therapeutic target - possibilities and pitfalls. (external link)
• Krakstad, Camilla; Chekenya, Martha (2010). Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. (external link)

Doctoral dissertation

• Fonnes, Tina; Krakstad, Camilla (2018). Preclinical models and molecular biomarkers. Tools to improve treatment in endometrial carcinoma. (external link)
• Halle, Mari Kyllesø; Salvesen, Helga; Krakstad, Camilla (2017). Molecular alterations suggesting new treatment strategies in uterine carcinomas. (external link)
• Tangen, Ingvild Løberg; Salvesen, Helga; Krakstad, Camilla (2016). Hormone signaling related factors as biomarkers in endometrial cancer. (external link)
• Krakstad, Camilla (2005). The role of CaMKII and cA-PK in control of cell survival and death. (external link)

Academic chapter/article/Conference paper

• Salvesen, Helga Birgitte; Werner, Henrica Maria Johanna; Krakstad, Camilla (2013). PI3K Pathway in Gynecologic Malignancies. (external link)
• Gausdal, Gro; Krakstad, Camilla; Herfindal, Lars et al. (2007). Serine/Threonine Protein Phosphatases in Apoptosis. (external link)

Abstract

• Tangen, Ingvild Løberg; Krakstad, Camilla; Werner, Henrica Maria Johanna et al. (2013). FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. (external link)
• Wik, Elisabeth; Rader, Maria; Krakstad, Camilla et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (external link)
• Wik, Elisabeth; Rader, Maria; Krakstad, Camilla et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (external link)

Reader opinion piece

• Halle, Mari Kyllesø; Werner, Henrica Maria Johanna; Krakstad, Camilla et al. (2012). Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas. (external link)

Poster

• Herfindal, Lars; Myhren, Lene Elisabeth; Kleppe, Rune et al. (2010). Liver specific transporters of microcystins as a tool to find novel inhibitors of OATP1B1 and OATP1B3. (external link)
• Sandal, Tone; Krakstad, Camilla; Ånensen, Nina et al. (2003). Myeloid leukemia cell differentiation by bcl-2 and camp involves induction of ccaat/enhancer binding protein ? (c/ebp?), nuclear accumulation of c/ebp?, and direct interaction between bcl-2 and c/ebp?. (external link)
• Herfindal, Lars; Selheim, Frode; Aursland, Kjetil et al. (2002). Effects of a new bioactive substance from a marine microalga on mammalian cells. (external link)
• Herfindal, Lars; Krakstad, Camilla; Selheim, Frode et al. (2001). TWO NOVEL APOPTOSIS-MODULATION SUBSTANCES ISOLATED FROM MARINE MICRO-ALGAE. (external link)

Masters thesis

• Selheim, Frode; Krakstad, Camilla; Birkeland, Even (2008). Quantitative proteomics of Epac signaling in differentiating human SH-SY5Y neuroblastoma cells. (external link)
• Ljones, Marie Louise; Krakstad, Camilla; Selheim, Frode (2008). Epac-induced neuronal differentiation of Human SH-SY5Y neuroblastoma cells. (external link)
• Fismen, Lise; Fladmark, Kari Espolin; Krakstad, Camilla (2005). Role of Cu/Zn superoxide dismutase (SOD1) in phosphatase inhibitor-induced apoptosis. (external link)

Academic lecture

• Krakstad, Camilla (2004). Apoptotic phenotypes induced by natural toxins - Okadaic Acid acts by short-circuiting an ancient irradiation induced death pathway. (external link)
• Krakstad, Camilla (2004). cAMP protects neutrophils against TNF_-induced apoptosis by activation of cAMP-dependent protein kinase (cA-PK), independently of exchange protein directly activated by cAMP (Epac). (external link)
• Krakstad, Camilla; Christensen, Anne Elisabeth; Døskeland, Stein Ove (2004). cAMP protects neutrophils against TNFa-induced apoptosis by activation of cAMP-dependent protein kinase (cA-PK), independently of exchange protein directly activated by cAMP (Epac). (external link)
• Kopperud, Reidun; Krakstad, Camilla; Selheim, Frode et al. (2003). cAMP effector mechanisms. Novel twists for an "old" signalling system. (external link)
• Krakstad, Camilla; Christensen, Anne Elisabeth; Døskeland, Stein Ove (2002). cAMP protects neutrophils against TNF_-induced apoptosis by activation of cAMP-dependent protein kinase (cA-PK), independently of exchange protein directly activated by cAMP (Epac). (external link)
• Krakstad, Camilla; Døskeland, Stein Ove (2001). Cell death in HeLa cells. (external link)
• Døskeland, Stein Ove; Fladmark, Kari Espolin; Krakstad, Camilla et al. (1998). Distinct apoptotic death forms. Distinct pathways and functions?. (external link)

See a complete overview of publications in Cristin.